Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Female”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03549000
What this trial is testing

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
Novartis Pharmaceuticals 127
Early research (Phase 1)Study completedNCT03101280
What this trial is testing

A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer

Who this might be right for
Gynecologic Neoplasms
Hoffmann-La Roche 29
Early research (Phase 1)Study completedNCT04640480
What this trial is testing

Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors

Who this might be right for
Colorectal CancerBreast CancerPancreas Cancer+4 more
SN BioScience 21
Early research (Phase 1)Study completedNCT00600496
What this trial is testing

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

Who this might be right for
Breast CancerBreast NeoplasmsColon Cancer+5 more
AstraZeneca 140
Testing effectiveness (Phase 2)Study completedNCT00754325
What this trial is testing

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Who this might be right for
Advanced Breast Cancer
Bristol-Myers Squibb 100
Large-scale testing (Phase 3)Study completedNCT02600923
What this trial is testing

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

Who this might be right for
Advanced Breast Cancer Female
Pfizer 131
Early research (Phase 1)Study completedNCT03109080
What this trial is testing

Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Neoplasms, Triple-NegativeBreast Neoplasm Malignant FemaleRadiotherapy Side Effect
Institut Curie 24
Early research (Phase 1)Study completedNCT03841110
What this trial is testing

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaGastric Cancer+15 more
Fate Therapeutics 37
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Early research (Phase 1)Study completedNCT02069158
What this trial is testing

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

Who this might be right for
Breast CancerNSCLCOvary Cancer+3 more
Cristiana Sessa 17
Large-scale testing (Phase 3)Study completedNCT01998906
What this trial is testing

Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 330
Early research (Phase 1)Study completedNCT02338349
What this trial is testing

A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer

Who this might be right for
Advanced ER+, HER2-Negative Breast Cancer
Stemline Therapeutics, Inc. 57
Early research (Phase 1)Active Not RecruitingNCT06036121
What this trial is testing

ADRX-0706 in Select Advanced Solid Tumors

Who this might be right for
Solid TumorsTriple Negative Breast Cancer (TNBC)Urothelial Cancer+1 more
Adcentrx Therapeutics 144
Testing effectiveness (Phase 2)Study completedNCT00247663
What this trial is testing

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Who this might be right for
Postmenopausal Women With Advanced Breast Cancer
Novartis Pharmaceuticals 17
Early research (Phase 1)Study completedNCT01300533
What this trial is testing

BIND-014 Given to Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerCancerSolid Tumors
BIND Therapeutics 58
Not applicableActive Not RecruitingNCT01505400
What this trial is testing

Integrated Molecular Profiling in Advanced Cancers Trial

Who this might be right for
Breast CancerNon-small Cell Lung CancerColorectal Cancer+7 more
University Health Network, Toronto 3,026
Early research (Phase 1)Ended earlyNCT04665921
What this trial is testing

SGN-STNV in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungHER2 Negative Breast NeoplasmsOvarian Neoplasms+9 more
Seagen Inc. 111
Early research (Phase 1)Temporarily pausedNCT05967533
What this trial is testing

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+13 more
University of California, Davis 100
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Early research (Phase 1)Active Not RecruitingNCT06257264
What this trial is testing

Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Who this might be right for
Breast CancerSmall Cell Lung CancerOvarian Cancer+9 more
BeiGene 103
Next Page